1. Home
  2. ATYR vs VATE Comparison

ATYR vs VATE Comparison

Compare ATYR & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.84

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$4.08

Market Cap

74.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
VATE
Founded
2005
1994
Country
United States
United States
Employees
59
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
74.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ATYR
VATE
Price
$0.84
$4.08
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$4.20
N/A
AVG Volume (30 Days)
1.4M
12.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,107,100,000.00
Revenue This Year
$9,628.95
N/A
Revenue Next Year
$156.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$4.05
52 Week High
$7.29
$9.01

Technical Indicators

Market Signals
Indicator
ATYR
VATE
Relative Strength Index (RSI) 43.50 27.57
Support Level $0.82 $4.11
Resistance Level $0.85 $5.37
Average True Range (ATR) 0.07 0.27
MACD -0.02 -0.07
Stochastic Oscillator 7.78 11.84

Price Performance

Historical Comparison
ATYR
VATE

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: